Parkinson's & Movement disorders

Gut bacteria could be responsible for side effect of Parkinson's drug

Bacteria in the small intestine can deaminate levodopa, the main drug that is used to treat Parkinson's disease. Bacterial processing of the unabsorbed fractions of the drug results in a metabolite that reduces gut motility. ...

Parkinson's & Movement disorders

Parkinson's disease can affect the eyes, and here's what we know so far

Parkinson's disease is the second most common neurodegenerative disease, affecting over 10 million people worldwide. It's characterized by changes in movement, including tremors, and slower and more rigid movements. But researchers ...

Parkinson's & Movement disorders

People with Parkinson's disease can have a brighter future

Well over six million people globally have been diagnosed with Parkinson's disease, which has an enormous impact on the lives of patients and their families and incurring mounting costs for society. In this special supplement ...

Parkinson's & Movement disorders

Parkinson's disease is not one, but two diseases

Although the name may suggest otherwise, Parkinson's disease is not one but two diseases, starting either in the brain or in the intestines. Which explains why patients with Parkinson's describe widely differing symptoms, ...

Alzheimer's disease & dementia

Biomarker indicating neurodegeneration identified in the eye

A new study led by Boston Medical Center researchers indicates a well-known biomarker that serves as a marker for earlier diagnosis of neurodegenerative diseases is now detectable in the eye. Neurofilament light chain, a ...

Neuroscience

Improving prediction of Parkinson's disease

Including genetic markers in addition to well known risk factors improves tests to predict Parkinson's disease, according to a study led by Queen Mary University of London.

page 39 from 40